Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease

Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease

Abstract Congenital metabolic diseases are a group of hereditary disorders caused by the deficiency of a single specific enzyme activity. Without appropriate therapy, affected patients suffer severe neurologic disability and eventual death. The current mainstays of management attempt to slow disease...

Full description

Bibliographic Details
Main Authors: Chika Takano, Brendan H. Grubbs, Mika Ishige, Erika Ogawa, Ichiro Morioka, Satoshi Hayakawa, Toshio Miki
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Stem Cells Translational Medicine
Subjects:
cell transplantation
cellular therapy
liver regeneration
placenta
stem cell transplantation
Online Access:https://doi.org/10.1002/sctm.20-0225

Internet

https://doi.org/10.1002/sctm.20-0225

Similar Items